|
|
Lixin Xu
Peer-Reviewed Papers
In Press
Valdez Y, Mah W, Winslow MM, Xu L, Ling P, Townsend SE.
MHC Class II presentation of Cell-Associated Antigen is mediated by CD8a+DC in vivo.
J of Experimental Medicine.
(In Press). Request Paper
2001
St. Louis J, Uniyal S, Xu L, Chan E-L, Singh B, Chan BMC, Strejan GH.
Tolerance induction by acylated peptides: suppression of EAE in themouse with Palmitoylated PLP peptides.
J of Neuroimmunology 115:79-90
(2001). Request Paper
2000
Xu L, Feng J, Tang J et al.
The immunohistochemical study of T cell phenotype in human ovarian epithelial carcinoma.
Chinese J of Histochemistry and Cytochemistry 9(4):390
(2000). Request Paper
Xu L, Feng J, Tang J et al.
The expression of major histocompatibility complex in human ovarian epithelial carcinoma.
J of Beijing Medical University 32(6):496
(2000). Request Paper
URL: http://www.bccrc.ca/ce/pubs_lxu.html
The BC Cancer Agency Research Centre is the research arm of the BC Cancer Agency (BCCA), and is supported by the BC Cancer Foundation.
This page was last modified at 11:26am on July 30, 2002
© 1999-2008.
BC Cancer Agency. All rights reserved.
About this website...
|
|
|
|
Navigation Menu
View Site Map
Contact Us
BC Cancer Agency Research Centre
675 West 10th Avenue
Vancouver, BC
V5Z 1L3 Canada
1-604-675-8000
| |
|